Galactooligosaccharide Mixture for Lowering Cholesterol and Triglycerides
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for managing metabolic syndrome are inadequate in effectively reducing the risk of cardiovascular disorders and diabetes, as they often rely on lifestyle changes and medications that may not comprehensively address the underlying metabolic risk factors.
Innovation Solution
A composition comprising a mixture of galactooligosaccharides, specifically disaccharides, trisaccharides, tetrasaccharides, and pentasaccharides, which are fermented by colonic bacteria, is orally administered to lower cholesterol and triglyceride levels, thereby reducing the risk of metabolic syndrome and associated cardiovascular disorders.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If lifestyle changes and medications are recommended to manage metabolic syndrome, then blood pressure, cholesterol and blood sugar levels are reduced, but the comprehensive effectiveness in reducing cardiovascular risk and diabetes risk remains inadequate
Solution Approach 1:
The patent introduces galactooligosaccharides as an intermediary substance that mediates between dietary intake and metabolic health outcomes. These non-digestible carbohydrates act as prebiotics that selectively stimulate the growth of beneficial gut bacteria, which in turn produce metabolites that improve lipid profiles, reduce inflammation, and enhance insulin sensitivity, thereby comprehensively addressing multiple metabolic syndrome risk factors through a single dietary intervention
2Reliability
If multiple medications are prescribed to reduce blood pressure, LDL cholesterol and blood sugar, then individual risk factors are addressed, but the overall risk reduction for heart disease and diabetes is insufficient
Solution Approach 1:
The patent applies the universality principle by demonstrating that galactooligosaccharides perform multiple therapeutic functions simultaneously: they lower total cholesterol and LDL cholesterol, reduce triglycerides, improve HDL cholesterol, reduce inflammatory markers, and enhance insulin sensitivity. This single prebiotic intervention universally addresses multiple metabolic syndrome components that would otherwise require multiple separate medications and lifestyle modifications
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The administration of this galactooligosaccharide mixture significantly increases beneficial gut bacteria, reduces inflammatory markers, and lowers insulin, cholesterol, and triglyceride levels, effectively mitigating the risk of metabolic syndrome and related cardiovascular issues.
Implementation Method 1
Galactooligosaccharides are non-digestible carbohydrates which are resistant to mammalian gastrointestinal digestive enzymes but are fermented by specific colonic bacteria
Data Source
AI summary
The present invention relates to the use of a galactooligosaccharide composition for preventing or reducing the risk of developing metabolic syndrome.